Psoriasis is a chronic, inflammatory, and multifactorial skin disorder of unknown origin. Till date, various clinical studies have analyzed the efficacy and safety profiles of various antipsoriatic drugs. However, with the increasing number of head-to-head trials on psoriasis, it is necessary to evaluate the relevance of these trials. This will allow the physicians to make better clinical decisions and choose the best biologics for their patients. Lilly and Docplexus have organized an interactive Webinar on 7th May 2020 at 3:00 PM GST. In this Webinar session, Dr.
Kim Papp will discuss the patients’ needs and preferences during psoriasis condition. Furthermore, Dr. Papp will also highlight the importance of indirect comparisons in selecting effective treatment options in such a patient population. Agenda : To discuss the following focus areas. Patient needs and preferences in psoriasis…
